Unknown

Dataset Information

0

TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.

ABSTRACT: Currently there is no neuroprotective or neurorestorative therapy for Parkinson's disease. Here we report that transient receptor potential vanilloid 1 (TRPV1) on astrocytes mediates endogenous production of ciliary neurotrophic factor (CNTF), which prevents the active degeneration of dopamine neurons and leads to behavioural recovery through CNTF receptor alpha (CNTFR?) on nigral dopamine neurons in both the MPP(+)-lesioned or adeno-associated virus ?-synuclein rat models of Parkinson's disease. Western blot and immunohistochemical analysis of human post-mortem substantia nigra from Parkinson's disease suggests that this endogenous neuroprotective system (TRPV1 and CNTF on astrocytes, and CNTFR? on dopamine neurons) might have relevance to human Parkinson's disease. Our results suggest that activation of astrocytic TRPV1 activates endogenous neuroprotective machinery in vivo and that it is a novel therapeutic target for the treatment of Parkinson's disease.

SUBMITTER: Nam JH 

PROVIDER: S-EPMC4840550 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Currently there is no neuroprotective or neurorestorative therapy for Parkinson's disease. Here we report that transient receptor potential vanilloid 1 (TRPV1) on astrocytes mediates endogenous production of ciliary neurotrophic factor (CNTF), which prevents the active degeneration of dopamine neurons and leads to behavioural recovery through CNTF receptor alpha (CNTFRα) on nigral dopamine neurons in both the MPP(+)-lesioned or adeno-associated virus α-synuclein rat models of Parkinson's disease  ...[more]

Similar Datasets

Unknown Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease.
| S-EPMC3837375 | biostudies-literature
Unknown Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
| S-EPMC6052763 | biostudies-literature
Unknown Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.
| S-EPMC4144978 | biostudies-literature
Unknown Reversing a model of Parkinson's disease with in situ converted nigral neurons.
| S-EPMC7521455 | biostudies-literature
Unknown Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.
| S-EPMC2810324 | biostudies-literature
Unknown Endogenous calcium buffering capacity of substantia nigral dopamine neurons.
| S-EPMC2775382 | biostudies-other
Unknown Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease.
| S-EPMC9050538 | biostudies-literature
Unknown PGC-1? activity in nigral dopamine neurons determines vulnerability to ?-synuclein.
| S-EPMC4379693 | biostudies-literature
Unknown Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.
| S-EPMC4114139 | biostudies-literature
Unknown Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson's disease.
| S-EPMC9033791 | biostudies-literature